Patients with malignant tumors of the pancreas tend to have a higher degree of malignancy, and their clinical symptoms are often atypical, so the possibility of radical surgical removal of the tumor is low, and their clinical prognosis is poor. Generally speaking, patients with pancreatic malignant tumors have different considerations according to the severity of the disease and whether they can be treated with radical surgery. Let’s learn more about it. If the patient’s pancreatic malignant tumor is early, at this time, the patient needs to pay attention to clarify the degree of progression of the disease in time, and the lesion site can be clarified by ultrasonography or enhanced CT or MRI. Once the disease is clear, patients need to pay attention to early surgical treatment to achieve complete cure of the tumor as far as possible. Special attention should be paid to avoid delaying the consultation and delaying the development of the tumor lesion to the middle and late stages, and losing the opportunity of surgery. For patients with mid to late stage pancreatic malignant tumor, the patient loses the chance of surgical resection at this time, but the patient’s general physical condition is still acceptable. At present, medical treatment is constantly developing, so you can choose chemotherapy drugs regular chemotherapy, through gene detection targeted therapy and other methods to kill pancreatic malignant tumor cells in the body as much as possible, inhibit the progress of malignant tumor, improve patient treatment, reduce patient pain and prolong patient life. Patients with advanced pancreatic malignant tumor are in more serious condition at this time. Patients often show extreme hypoproteinemic malnutrition due to loss of appetite and serious weight loss. At this time, we should pay attention to give patients sufficient intravenous nutrition, maintain electrolyte stability and acid-base balance to avoid patients’ life threatening due to electrolyte disorder and acid-base metabolic imbalance.